By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Millipore said today that with the completion of its purchase by Merck KGaA, it is delivering a notice to holders of its 3.75 percent Convertible Senior Notes due 2026 that the effective date of the Make-Whole Fundamental Change was July 14, when the deal was completed.

The purchase's completion also triggered an increase in the conversion rate "applicable to notes surrendered for conversion during the Make-Whole Conversion period," Millipore said.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: swapping yeast genes with human orthologs to study conservation of function, and more.

Hong Kong is using DNA phenotyping to shame litterers.

A study appearing in Cell suggests some metastatic castration-resistant prostate cancer patients could benefit from PARP inhibitor therapy.

NIH's Francis Collins writes that scientific advances are poised to help populations all over the world, but more scientists are needed to keep the momentum.